Insider · CIK 0001778483
Jeffrey Sevigny
Files at RAPP (Rapport Therapeutics, Inc.). First filing -, latest -.
Jeffrey Sevigny files SEC Form 4 as officer at RAPP (Rapport Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeffrey Sevigny has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | RAPP Rapport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +130,000 | $0.00 | $0 | 130,000 | Feb 4, 2026 |
| Apr 1, 2025 | RAPP Rapport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Apr 3, 2025 |
Questions about Jeffrey Sevigny
Answered from the filings on this page, as of the latest one.
Is Jeffrey Sevigny buying or selling?
Jeffrey Sevigny has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeffrey Sevigny's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey Sevigny has 0.
Where does Jeffrey Sevigny file Form 4?
Jeffrey Sevigny has filed Form 4 at RAPP (Rapport Therapeutics, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.